Moreover, CBD could still reverse the phenotypes of PAH both in WT and Cnr2-/- mice, which strongly implicated that the inhibitory effects of CBD on PAH in vivo was Cnr2-independent. This evidence concerns the gene CNR2 and pulmonary arterial hypertension.